Archivel Farma S.L.   Report issue

For profit Phase 2 Phase 3
Founded: Badalona Spain (2005)

Organization Overview

First Clinical Trial
2007
NCT00546273
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Archivel Farma S.L. | RUTI Immunotherapeutics S.L.

Active Ingredients

Drugs in Phase 3 Trials (1)

liposomed heat-inactivated mycobacterium tuberculosis bacilli (3 trials)

Drugs in Phase 2 Trials (1)

ruti (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Latent Tuberculosis (Phase 2)

Tuberculosis (Phase 2)

Tuberculosis, Multidrug-Resistant (Phase 2)

Urinary Bladder Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 2